Published in J Musculoskelet Neuronal Interact on September 01, 2012
Twenty-five years of research on the effects of exercise training in breast cancer survivors: A systematic review of the literature. World J Clin Oncol (2014) 0.93
Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors. Breast Cancer Res Treat (2015) 0.84
Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy. BMC Cancer (2017) 0.75
Effects of a progressive aquatic resistance exercise program on the biochemical composition and morphology of cartilage in women with mild knee osteoarthritis: protocol for a randomised controlled trial. BMC Musculoskelet Disord (2013) 0.75
Effect of progressive high-impact exercise on femoral neck structural strength in postmenopausal women with mild knee osteoarthritis: a 12-month RCT. Osteoporos Int (2016) 0.75
Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance. Osteoporos Int (2012) 3.48
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst (2000) 3.12
Epidemiology of hip fractures. Bone (1996) 2.54
Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet (1996) 2.46
Good maintenance of exercise-induced bone gain with decreased training of female tennis and squash players: a prospective 5-year follow-up study of young and old starters and controls. J Bone Miner Res (2001) 2.37
Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma. Ann Oncol (2009) 2.35
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer (2000) 2.34
Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res (1995) 2.31
Effect of starting age of physical activity on bone mass in the dominant arm of tennis and squash players. Ann Intern Med (1995) 2.06
Preventing excessive weight gain during pregnancy - a controlled trial in primary health care. Eur J Clin Nutr (2007) 1.91
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer. Br J Cancer (1997) 1.81
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol (1997) 1.80
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer (2004) 1.79
Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions. J Bone Miner Res (2003) 1.77
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial. J Clin Oncol (2001) 1.76
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res (2001) 1.74
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF. Br J Cancer (1999) 1.67
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67
Antisense inhibition of protein phosphatase 2C accelerates cold acclimation in Arabidopsis thaliana. Plant J (2001) 1.64
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
High-impact exercise and bones of growing girls: a 9-month controlled trial. Osteoporos Int (2000) 1.52
Radioimmunoassay of digoxin. Lancet (1972) 1.52
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Bacteriology of chronic otitis media. Results of analyses from the ear canal and from the operative cavity. Arch Otolaryngol (1965) 1.47
Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol (1999) 1.44
The long-term effect of early mineral, vitamin D, and breast milk intake on bone mineral status in 9- to 11-year-old children born prematurely. J Pediatr Gastroenterol Nutr (1999) 1.44
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer (2001) 1.44
Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci (2001) 1.44
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be proved. Ann Oncol (2011) 1.42
Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer (2001) 1.41
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene (2007) 1.39
Short communication: subcellular localization of ozone-induced hydrogen peroxide production in birch (Betula pendula) leaf cells. Plant J (1999) 1.38
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial. Ann Oncol (2003) 1.38
Effect of long-term unilateral activity on bone mineral density of female junior tennis players. J Bone Miner Res (1998) 1.37
Adenosine deaminase in the diagnosis of pleural effusions. Acta Med Scand (1984) 1.35
Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet (1999) 1.34
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther (2007) 1.33
Effect of 4-min vertical whole body vibration on muscle performance and body balance: a randomized cross-over study. Int J Sports Med (2002) 1.33
High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer (2009) 1.33
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology (2007) 1.33
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer (1998) 1.32
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone (1994) 1.31
Acquired tracheobronchomalacia. Ann Clin Res (1977) 1.30
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet (2000) 1.27
Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas (2010) 1.26
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet (1983) 1.20
Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility. J Bone Miner Res (2001) 1.20
Site-specific skeletal response to long-term weight training seems to be attributable to principal loading modality: a pQCT study of female weightlifters. Calcif Tissue Int (2002) 1.19
Estimation of various mechanical characteristics of human bones using dual energy X-ray absorptiometry: methodology and precision. Bone (1996) 1.17
Continuous decline in incidence of hip fracture: nationwide statistics from Finland between 1970 and 2010. Osteoporos Int (2012) 1.16
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer (2001) 1.15
DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer (1999) 1.15
Bone mineral density in female athletes representing sports with different loading characteristics of the skeleton. Bone (1995) 1.14
Anaerobic bacteria in chronic otitis media. Arch Otolaryngol (1977) 1.14
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer (1997) 1.14
Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum. Scand J Infect Dis (1974) 1.14
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer (2012) 1.13
Finnish approach to the treatment of acute otitis media. Report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl (1987) 1.13
Mineral mass, size, and estimated mechanical strength of triple jumpers' lower limb. Bone (2001) 1.13
Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients. Eur J Cancer (2000) 1.12
Targeted exercises against hip fragility. Osteoporos Int (2008) 1.12
Bone mineral density of female athletes in different sports. Bone Miner (1993) 1.11
Determination of amylase activity and amylase isoenzymes in serum and urine using a solid phase blue starch substrate. Scand J Clin Lab Invest (1975) 1.11
Radical mastoidectomy with cavity obliteration. Arch Otolaryngol (1968) 1.10
Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed (1999) 1.10
Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol (1997) 1.10
Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int (2008) 1.10
A multi-component exercise regimen to prevent functional decline and bone fragility in home-dwelling elderly women: randomized, controlled trial. Osteoporos Int (2006) 1.09
Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG (2000) 1.09
Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone (2003) 1.09
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer (2003) 1.08
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort. Int J Cancer (2010) 1.08
Have the DXA-based exercise studies seriously underestimated the effects of mechanical loading on bone? J Bone Miner Res (1999) 1.08
Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation. J Bone Miner Res (2001) 1.08
Operative technique in mastoid obliteration. Acta Otolaryngol (1973) 1.07
Vestibular findings in patients with acoustic neurinoma. Arch Otolaryngol (1980) 1.06
Associations between health-related behaviors: a 7-year follow-up of adults. Prev Med (2002) 1.06
Cochlear aqueduct in infants. Acta Otolaryngol (1970) 1.05
Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr (2000) 1.05
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer (2001) 1.03
Comparison of pre- and post-operative bacteriology of chronic ears. J Laryngol Otol (1981) 1.03
Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol (1989) 1.03
Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet Cytogenet (1997) 1.03
Chronic bronchitis. A bronchologic evaluation. ORL J Otorhinolaryngol Relat Spec (1976) 1.03
Changes in bone mineral content with decreased training in competitive young adult tennis players and controls: a prospective 4-yr follow-up. Med Sci Sports Exerc (1999) 1.03
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer (2009) 1.03
Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psychooncology (2010) 1.02
The site-specific effects of long-term unilateral activity on bone mineral density and content. Bone (1994) 1.02